Department of Radiology, European Institute of Oncology, Milan, Italy.
Specialisation School of Radiology, University of Milan, Milan, Italy.
Eur Radiol. 2016 Dec;26(12):4432-4441. doi: 10.1007/s00330-016-4284-8. Epub 2016 Mar 10.
To assess the independent prognostic value of standardized uptake value (SUV) and apparent diffusion coefficient (ADC), separately and combined, in order to evaluate if the combination of these two variables allows further prognostic stratification of patients with head and neck squamous cell carcinomas (HNSCC).
Pretreatment SUV and ADC were calculated in 57 patients with HNSCC. Mean follow-up was 21.3 months. Semiquantitative analysis of primary tumours was performed using SUV, ADC, ADC and ADC. The prognostic value of SUV, ADC, ADC and ADC in predicting disease-free survival (DFS) was evaluated with log-rank test and Cox regression models.
Patients with SUV ≥5.75 had an overall worse prognosis (p = 0.003). After adjusting for lymph node status and diameter, SUV and ADC were both significant predictors of DFS with hazard ratio (HR) = 10.37 (95 % CI 1.22-87.95) and 3.26 (95 % CI 1.20-8.85) for SUV ≥5.75 and ADC ≥0.58 × 10 mm/s, respectively. When the analysis was restricted to subjects with SUV ≥5.75, high ADC significantly predicted a worse prognosis, with adjusted HR = 3.11 (95 % CI 1.13-8.55).
The combination of SUV and ADC improves the prognostic role of the two separate parameters; patients with high SUV and high ADC are associated with a poor prognosis.
• High SUV is a poor prognostic factor in HNSCC • High ADC is a poor prognostic factor in HNSCC • In patients with high SUV , high ADC identified those with worse prognosis.
评估标准化摄取值(SUV)和表观扩散系数(ADC)的独立预后价值,分别和联合,以评估这两个变量的组合是否可以进一步对头颈部鳞状细胞癌(HNSCC)患者进行预后分层。
对 57 例 HNSCC 患者进行 SUV 和 ADC 的预处理。平均随访时间为 21.3 个月。采用 SUV、ADC、ADC 和 ADC 对原发肿瘤进行半定量分析。采用对数秩检验和 Cox 回归模型评估 SUV、ADC、ADC 和 ADC 对无病生存(DFS)的预测价值。
SUV≥5.75 的患者总体预后较差(p=0.003)。在调整淋巴结状态和直径后,SUV 和 ADC 均为 DFS 的显著预测因素,SUV≥5.75 和 ADC≥0.58×10 mm/s 的风险比(HR)分别为 10.37(95%CI 1.22-87.95)和 3.26(95%CI 1.20-8.85)。当分析仅限于 SUV≥5.75 的患者时,高 ADC 显著预测预后不良,调整后的 HR=3.11(95%CI 1.13-8.55)。
SUV 和 ADC 的联合应用提高了两个独立参数的预后作用;SUV 高和 ADC 高的患者预后不良。
SUV 高是 HNSCC 的不良预后因素。
ADC 高是 HNSCC 的不良预后因素。
在 SUV 高的患者中,高 ADC 可识别出预后较差的患者。